Roles
BMHA Training Faculty, HALO Faculty
Dr. Melissa Barker-Haliski’s research emphasizes developing novel strategies and preclinical approaches to uncover precision medicines for unmet medical needs for older adults with epilepsy and for seizures related to neurodegenerative disease, including Alzheimer’s disease. Using a variety of behavioral models and molecular neuroscience techniques, the lab is particularly interested in therapeutic discovery and neuropharmacological interactions to understand changes in neuronal hyperexcitability across the lifespan. She is currently co-chair of the International League Against Epilepsy (ILAE) Preclinical Precision Medicine Working Group and Vice Chair of the American Epilepsy Society Translational Task Force. Dr. Barker-Haliski actively engages with industry and government leaders to drive next-generation therapeutic discovery for late-life seizures
